Buys
Open market- Shares
- Avg price
- Total value
Dov A. Goldstein MD - Chief Financial Officer at BioAge Labs, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- BIOA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Dov A. Goldstein MD in BioAge Labs, Inc.
Sells
Open market- Shares
- -27,000
- Avg price
- $19.70
- Total value
- -$531,828
Net
Past year- Shares
- -27,000
- Share %
- -100%
- Total value
- -$531,828
Reported holdings for Dov A. Goldstein MD in BioAge Labs, Inc.
Form 4 holding
Chief Financial Officer
BioAge Labs, Inc.
- Security class
- Common Stock
- Shares / value
- 36,575
- Estimated value
- $639,718
- Report date
- 23 Apr 2026
- Price
- $17.49
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
BioAge Labs, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 155,833
- Estimated value
- Report date
- 23 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Dov A. Goldstein MD in BioAge Labs, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.